{"id":"W2594478488","doi":"10.1158/1538-7445.sabcs16-pd2-07","title":"Abstract PD2-07: 10-year follow-up and biomarker discovery for adjuvant endocrine therapy; results of the TEAM trial","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Exemestane; Medicine; Internal medicine; Oncology; Breast cancer; Hazard ratio; Tamoxifen; Clinical endpoint; Adjuvant therapy; Cancer; Randomized controlled trial; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004477691,0.0007453365,0.001667494,0.0002498383,0.0003555337,0.001655325,0.0006821287,0.001310849,0.004220158],"category_scores_gemma":[0.003617773,0.0002910014,0.002105682,0.0005008951,0.0005606199,0.001140347,0.0007553545,0.002316688,0.0008741757],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005087706,"about_ca_system_score_gemma":0.0008571693,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004970827,"about_ca_topic_score_gemma":0.0006802214,"domain_scores_codex":[0.9979079,0.001464792,0.0001069174,0.0002467138,0.0001671277,0.00010659],"domain_scores_gemma":[0.9976075,0.0007318107,0.00062861,0.0003148899,0.0001788761,0.0005383731],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.9627966,0.001364074,0.009299498,0.0004002246,0.002610692,0.00005243267,0.00004665389,0.0006085096,0.001063637,0.0002432176,0.004116045,0.01739847],"study_design_scores_gemma":[0.7704946,0.1511607,0.05491733,0.0002613486,0.008320464,0.0002610248,0.0001477473,0.003393422,0.001262338,0.001341259,0.008352961,0.000086769],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9749539,0.006410143,0.001315964,0.001343535,0.0004691217,0.001500885,0.007180896,0.00009798175,0.00672755],"genre_scores_gemma":[0.9794113,0.00162258,0.001332766,0.001293828,0.0005590501,0.002327473,0.009655541,0.00004323192,0.003754313],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004477691,"threshold_uncertainty_score":0.02368057,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.144528455159949,"score_gpt":0.452491500223539,"score_spread":0.30796304506359,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}